"The reason compounders had to do this was because there was so much demand for GLP-1s that there was actually a national shortage." Current legislation allows compounders to step in during widespread national shortages, according to Tatem, prompting the industry to invest millions of dollars into developing and manufacturing these drugs
224 SinghS.SharmaN.ZahoorI.BehlT.AntilA.GuptaS.et al (2023)
Compounded Alternatives For patients without coverage, compounded semaglutide and tirzepatide are available through telehealth providers at $99$450 per month
MRI-based determination of proton density fat fraction (PDFF) adds an additional capacity for staging the grades of steatosis present, suggesting that it may be of utility in monitoring NAFLD patients for progression to NASH (Kang et al., 2011
Understanding these risks is essential for any research context
Kopp KO, Glotfelty EJ, Li Y, Greig NH (2022) Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: implications for neurodegenerative disease treatment